(0)サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1747721

経口腸チフス・ワクチンの世界市場

Oral Typhoid Vaccines

出版日
ページ情報
英文 183 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.50円
経口腸チフス・ワクチンの世界市場
出版日: 2025年06月13日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

経口腸チフス・ワクチンの世界市場は2030年までに2億4,870万米ドルに達する見込み

2024年に1億3,830万米ドルと推定される経口腸チフス・ワクチンの世界市場は、2030年には2億4,870万米ドルに達し、分析期間2024-2030年のCAGRは10.3%で成長すると予測されます。本レポートで分析したセグメントの1つである病院薬局流通チャネルは、CAGR 9.4%を記録し、分析期間終了時には1億4,260万米ドルに達すると予測されます。小売薬局流通チャネルセグメントの成長率は、分析期間中CAGR 11.2%と推定されます。

米国市場は3,770万米ドルと推定、中国はCAGR13.8％で成長予測

米国の経口腸チフス・ワクチン市場は、2024年に3,770万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR13.8％をたどり、2030年には予測市場規模5,050万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.5％と9.0％と予測されています。欧州では、ドイツがCAGR約8.1%で成長すると予測されています。

世界の経口腸チフス・ワクチン市場- 主要動向と促進要因まとめ

経口ワクチン戦略は流行地域の腸チフス対策に革命を起こせるか？

経口腸チフス・ワクチンは、主にSalmonella Typhi Ty21aのような生きた弱毒株をベースとしており、特にアジアやサハラ以南のアフリカの低資源・高負担地域において、腸チフス対策という世界戦略において変革的な役割を果たしています。注射タイプのVi多糖体ワクチンや結合型ワクチンとは異なり、経口製剤は針を使わない投与、粘膜免疫の刺激、集団予防接種キャンペーンへの展開の容易さといった利点を提供します。腸チフスの罹患率や死亡率を抑制するための世界の公衆衛生への取り組みが強化される中、経口ワクチンは、特に小児や青少年において、その拡張性や受容性から再び注目を集めています。

世界保健機関（WHO）は、経口ワクチンを旅行関連や流行性腸チフス対策に推奨しており、様々な人口層における非経口ワクチンの選択肢を補完する可能性を認めています。さらに、多剤耐性（MDR）や広範囲薬剤耐性（XDR）の腸チフスが増加していることから、予防ワクチン接種の重要性が高まっています。経口腸チフス・ワクチン抗生物質による治療の選択肢がますます限られてきている、あるいは効果がなくなってきている地域では、予防接種が重要な第一線となります。

なぜワクチンのコンプライアンスとコールドチェーンの利点が経口ワクチン普及の原動力となっているのか？

注射ワクチンとは対照的に、Vivotif（R）のような経口腸チフス・ワクチンは、投与に訓練を受けた医療従事者を必要とせず、針を刺す怪我や感染のリスクを軽減します。このため、医療インフラが限られた農村部や都市周辺部では特に効果的です。また経口ワクチンは、特に学校を拠点とする予防接種プログラムや旅行クリニックにおいて、より少ない物流障壁で複数回接種スケジュールを実施できるため、コンプライアンスも向上します。

さらに、経口ワクチンは通常、非経口ワクチンと比較してコールドチェーン耐性に優れています。製剤によっては、より広い温度範囲で安定性を示すものもあり、フィールドキャンペーン中の保管や輸送を簡素化できます。これらの特徴は、電気や冷蔵設備が不安定な遠隔地や災害の多い地域での支援活動には不可欠です。このような運用上の柔軟性により、経口腸チフス・ワクチンは緊急対応ツールキットや人道的保健活動に不可欠なものとなっています。

政策転換と公衆衛生プログラムは、どのようにワクチン普及を拡大させているのか？

国際的なドナー機関や各国の予防接種プログラムは、総合的な疾病管理における経口腸チフス・ワクチンの役割をますます認識しつつあります。Gavi、Vaccine Alliance、UNICEFが支援する公衆衛生パートナーシップは、乳幼児には注射用結合型ワクチン、高齢者や旅行者には経口ワクチンという二重のアプローチで流行地域へのワクチン導入を推進しています。インド、バングラデシュ、ネパール、ケニアなどの国では、経口ワクチンを渡航勧告、軍の健康プロトコル、難民の健康プログラムに組み込んでいます。

ワクチン接種後のサーベイランスデータにより、経口ワクチンを定期予防接種に広く含めるケースが強化されつつあります。研究によると、Ty21aベースのワクチンは腸チフス発症率を低下させるだけでなく、サルモネラ・パラチフィBに対する中程度の交差防御をもたらし、疫学的価値をさらに高めています。製薬メーカーは、保存安定性の向上、投与間隔の延長、小児用や幅広い株への適用をターゲットとした再製剤の開発などで対応しています。

経口腸チフス・ワクチンの世界の需要増加の原動力は？

経口腸チフス・ワクチン市場の成長の原動力は、腸チフスに対する意識の高まり、パンデミック後の世界の旅行再開、疾病予防インフラへの戦略的投資です。主な成長要因は、ヘルスケアへのアクセスが分断されている地域において、経口ワクチンが効率的で費用対効果の高いソリューションとして認知されつつあることです。世界の渡航勧告や大学の予防接種プログラムも、腸チフス流行地域への渡航者や駐在員の経口ワクチンの需要を支え続けています。

さらに、都市化、劣悪な衛生環境、気候に関連した水質汚染により、人口密集地では腸チフス感染のリスクが高まっており、予防的な公衆衛生対策が必要となっています。主要な経口ワクチンの規制当局による承認とWHOによる事前認定により、国際的なサプライチェーンを通じた調達が可能になり、市場へのアクセスがさらに拡大しています。抗菌薬耐性が高まる中、腸チフスが公衆衛生の優先課題として再浮上していることから、経口ワクチンは世界の予防接種戦略において、単独でも補完的なソリューションとしても引き続き支持を集めるでしょう。

ワクチン供給における継続的な技術革新、政策的承認の拡大、強固なサプライチェーン統合により、経口腸チフス・ワクチン市場は持続的な成長を遂げる位置にあります。これらのワクチンは、リスクの高い地域や移動人口の腸チフス制圧・制圧目標を達成するために不可欠な手段であり続けると思われます。

セグメント

流通チャネル（病院薬局、小売薬局、オンライン薬局）

調査対象企業の例（全42件）

  • Bavarian Nordic
  • Bharat Biotech
  • Bio Farma
  • Biological E. Limited
  • Crucell（a Johnson & Johnson company）
  • Emergent BioSolutions
  • GlaxoSmithKline plc（GSK）
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Panacea Biotec Ltd.
  • PaxVax（now part of Emergent BioSolutions）
  • PT Bio Farma
  • Sanofi Pasteur
  • Serum Institute of India
  • Shanta Biotechnics Ltd.
  • SK Bioscience
  • Takeda Pharmaceutical Company
  • Valneva SE
  • Zydus Cadila

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP35463

Global Oral Typhoid Vaccines Market to Reach US$248.7 Million by 2030

The global market for Oral Typhoid Vaccines estimated at US$138.3 Million in the year 2024, is expected to reach US$248.7 Million by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Hospital Pharmacies Distribution Channel, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$142.6 Million by the end of the analysis period. Growth in the Retail Pharmacies Distribution Channel segment is estimated at 11.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$37.7 Million While China is Forecast to Grow at 13.8% CAGR

The Oral Typhoid Vaccines market in the U.S. is estimated at US$37.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$50.5 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.5% and 9.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Oral Typhoid Vaccines Market - Key Trends & Drivers Summarized

Can Oral Vaccination Strategies Revolutionize Typhoid Control in Endemic Regions?

Oral typhoid vaccines, primarily based on live attenuated strains like Salmonella Typhi Ty21a, are playing a transformative role in the global strategy to combat enteric fever, particularly in low-resource, high-burden regions of Asia and sub-Saharan Africa. Unlike injectable Vi polysaccharide or conjugate vaccines, oral formulations offer the advantages of needle-free administration, mucosal immunity stimulation, and ease of deployment in mass immunization campaigns. As global public health efforts intensify to curb typhoid morbidity and mortality, oral vaccines are gaining renewed attention for their scalability and acceptability, especially in children and adolescents.

The World Health Organization (WHO) has endorsed oral vaccines for travel-related and endemic typhoid control, recognizing their potential to complement parenteral options in diverse population segments. Moreover, the increasing prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) typhoid strains has elevated the importance of preventive vaccination. Oral typhoid vaccines serve as a critical first line of defense in regions where antibiotic treatment options are becoming increasingly limited or ineffective.

Why Are Vaccine Compliance and Cold Chain Advantages Driving Oral Adoption?

In contrast to injectable vaccines, oral typhoid vaccines such as Vivotif® eliminate the need for trained healthcare workers for administration and reduce the risk of needle-stick injuries or infections. This makes them particularly effective in rural and peri-urban areas with limited medical infrastructure. Oral vaccines also promote higher compliance, especially in school-based vaccination programs or travel clinics, where multi-dose schedules can be administered with fewer logistical barriers.

Moreover, oral vaccines typically have better cold chain resilience compared to their parenteral counterparts. Some formulations demonstrate stability across a wider temperature range, simplifying storage and transportation during field campaigns. These features are critical for outreach in remote or disaster-prone regions where electricity and refrigeration are unreliable. Such operational flexibility is positioning oral typhoid vaccines as an integral part of emergency response toolkits and humanitarian health interventions.

How Are Policy Shifts and Public Health Programs Expanding Vaccine Uptake?

International donor agencies and national immunization programs are increasingly recognizing the role of oral typhoid vaccines in integrated disease control. Public health partnerships supported by Gavi, the Vaccine Alliance, and UNICEF are promoting vaccine introduction in endemic regions with a dual approach: deploying injectable conjugate vaccines for infants and oral vaccines for older age groups or travelers. Countries such as India, Bangladesh, Nepal, and Kenya are incorporating oral vaccines into travel advisories, military health protocols, and refugee health programs.

Post-vaccination surveillance data is strengthening the case for broader oral vaccine inclusion in routine immunization. Studies show that Ty21a-based vaccines not only reduce typhoid incidence but also confer moderate cross-protection against Salmonella Paratyphi B, further enhancing their epidemiological value. Pharmaceutical manufacturers are responding by improving shelf stability, extending dosage intervals, and developing reformulations targeted at pediatric use and wider strain coverage.

What’s Driving the Rising Global Demand for Oral Typhoid Vaccines?

The growth in the oral typhoid vaccines market is driven by rising awareness of typhoid burden, global travel resumption post-pandemic, and strategic investments in disease prevention infrastructure. A key growth driver is the increasing recognition of oral vaccines as an efficient, cost-effective solution in regions where healthcare access is fragmented. Global travel advisories and university immunization programs also continue to support demand for oral vaccines among travelers and expatriates to typhoid-endemic zones.

In addition, urbanization, poor sanitation, and climate-linked water contamination are sustaining typhoid transmission risks in densely populated regions-necessitating preventive public health measures. Regulatory approvals and WHO prequalification of key oral vaccines are enabling procurement through international supply chains, further expanding market accessibility. As typhoid re-emerges as a public health priority amid rising antimicrobial resistance, oral vaccines will continue to gain traction as both a standalone and complementary solution in global immunization strategies.

With ongoing innovations in vaccine delivery, expanded policy endorsement, and robust supply chain integration, the oral typhoid vaccines market is positioned for sustained growth. These vaccines will remain vital tools for achieving typhoid control and elimination goals across high-risk geographies and mobile populations.

SCOPE OF STUDY:

The report analyzes the Oral Typhoid Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Bavarian Nordic
  • Bharat Biotech
  • Bio Farma
  • Biological E. Limited
  • Crucell (a Johnson & Johnson company)
  • Emergent BioSolutions
  • GlaxoSmithKline plc (GSK)
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Panacea Biotec Ltd.
  • PaxVax (now part of Emergent BioSolutions)
  • PT Bio Farma
  • Sanofi Pasteur
  • Serum Institute of India
  • Shanta Biotechnics Ltd.
  • SK Bioscience
  • Takeda Pharmaceutical Company
  • Valneva SE
  • Zydus Cadila

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Oral Typhoid Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Global Travel and Migration Drives Demand for Oral Typhoid Immunization Among Adults
    • Expansion of National Immunization Programs Throws the Spotlight on Cost-Effective Oral Delivery Platforms
    • OEM Development of Next-Gen Ty21a and Vi-Conjugate Oral Vaccines Enhances Efficacy and Compliance
    • Growing Use in Emergency and Outbreak Response Scenarios Strengthens Case for Shelf-Stable Oral Formulations
    • Rising Incidence of Drug-Resistant Typhoid in Endemic Regions Propels Focus on Preventive Vaccination
    • OEM Collaboration With UNICEF and Gavi Enhances Access and Distribution in Developing Economies
    • Regulatory Approvals for Multi-Dose and Single-Dose Oral Vaccines Improve Coverage Among Pediatric Populations
    • OEM Investment in Microencapsulation and Enteric Coating Technologies Enhances Mucosal Immunity and Absorption
    • Use of Thermostable Oral Typhoid Vaccines in Remote Areas Expands Reach of Immunization Campaigns
    • Integration of Oral Vaccines in Travel Clinics and Pharmacies Drives Convenience-Based Administration
    • OEM Focus on Expanding Vaccine Shelf Life Supports Mass Immunization Logistics
    • Growth in Controlled Human Infection Models Accelerates Clinical Validation of Novel Oral Typhoid Candidates
    • Rising Public Awareness and Hygiene Education Strengthens Acceptance of Oral Immunoprophylaxis
    • OEM Entry Into Over-The-Counter and Retail Health Segments Enhances Non-Institutional Availability
    • Government Adoption of Oral Vaccine Guidelines for At-Risk Urban Populations Spurs Local Procurement
    • OEM Development of Combination Enteric Pathogen Vaccines Broadens Protective Spectrum
    • WHO Prequalification and National Tender Eligibility Accelerate Product Registrations and Supply Chain Access
    • Expansion of Public-Private Vaccine Initiatives Strengthens Market for Oral Typhoid Immunization
    • Challenges in Cold Chain Infrastructure Drive Innovation in Ambient-Temperature Oral Vaccine Logistics
    • Epidemiological Surveillance Systems Highlight Need for Targeted Immunization Strategies in High-Burden Areas
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Oral Typhoid Vaccines Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Oral Typhoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Oral Typhoid Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • JAPAN
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • CHINA
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • EUROPE
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Oral Typhoid Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Oral Typhoid Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • FRANCE
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • GERMANY
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Oral Typhoid Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Oral Typhoid Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • INDIA
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Oral Typhoid Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Oral Typhoid Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Oral Typhoid Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Oral Typhoid Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • AFRICA
    • Oral Typhoid Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Oral Typhoid Vaccines by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Oral Typhoid Vaccines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030

IV. COMPETITION